Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hemozink
- Development stage
- Unknown
- Lead developer
- Pharmaceuticals
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Hemozink is an over-the-counter (OTC) nutritional supplement syrup developed by Group Pharmaceutical. The formulation is a combination of iron, zinc, protein, and multiple vitamins, categorized under the company's consumer health and multi-specialty portfolio. It is intended for use in addressing nutritional deficiencies and supporting general wellness, with specific applications in woman care and nutritional health. As a multi-component product, it provides essential minerals and proteins necessary for various physiological processes, including the synthesis of hemoglobin and the maintenance of enzymatic activities.
- Brand names
- Hemozink
- Other names
- Hemozink
Beyond the preview
Go deeper on Hemozink.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemozink.